Cargando…

Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study

BACKGROUND: Oral semaglutide is the first glucagon-like peptide-1 receptor agonist (GLP-1RA) designed for oral administration; it offers a promising opportunity to facilitate an early approach to Type 2 Diabetes (T2D). The study aimed to evaluate, in a real-life setting, the effects of oral semaglut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Volpe, Sara, Lisco, Giuseppe, Fanelli, Margherita, Racaniello, Davide, Colaianni, Valentina, Lavarra, Valentina, Triggiani, Domenico, Crudele, Lucilla, Triggiani, Vincenzo, Sabbà, Carlo, De Pergola, Giovanni, Piazzolla, Giuseppina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534984/ https://www.ncbi.nlm.nih.gov/pubmed/37780624 http://dx.doi.org/10.3389/fendo.2023.1240263

Ejemplares similares

Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study
por: Volpe, Sara, et al.
Publicado: (2022)

Once-Weekly Semaglutide Induces an Early Improvement in Body Composition in Patients with Type 2 Diabetes: A 26-Week Prospective Real-Life Study
por: Volpe, Sara, et al.
Publicado: (2022)

Iodine Deficiency and Iodine Prophylaxis: An Overview and Update
por: Lisco, Giuseppe, et al.
Publicado: (2023)

Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience
por: Piazzolla, Giuseppina, et al.
Publicado: (2022)

Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis
por: Lisco, Giuseppe, et al.
Publicado: (2022)

Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?
por: Lisco, Giuseppe, et al.
Publicado: (2023)

Monocyte-to-HDL Ratio (MHR) Predicts Vitamin D Deficiency in Healthy and Metabolic Women: A Cross-Sectional Study in 1048 Subjects
por: De Matteis, Carlo, et al.
Publicado: (2022)

Interference on Iodine Uptake and Human Thyroid Function by Perchlorate-Contaminated Water and Food
por: Lisco, Giuseppe, et al.
Publicado: (2020)

Computerized nailfold video‐capillaroscopy in type 2 diabetes: A cross‐sectional study on 102 outpatients
por: Lisco, Giuseppe, et al.
Publicado: (2023)

The Effects of Eight Weeks’ Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity
por: Rinaldi, Roberta, et al.
Publicado: (2023)

Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review
por: Lisco, Giuseppe, et al.
Publicado: (2020)

Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition
por: Lisco, Giuseppe, et al.
Publicado: (2020)

Thyroid nodule malignancy is associated with increased non-invasive hepatic fibrosis scores in metabolic subjects
por: Crudele, Lucilla, et al.
Publicado: (2023)

Total serum FGF-21 levels positively relate to visceral adiposity differently from its functional intact form
por: Crudele, Lucilla, et al.
Publicado: (2023)

Effect of levothyroxine replacement therapy in patients with subclinical hypothyroidism and chronic heart failure: A systematic review
por: Triggiani, Vincenzo, et al.
Publicado: (2022)

Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis
por: Crudele, Lucilla, et al.
Publicado: (2022)

Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects
por: Lisco, G., et al.
Publicado: (2021)

Identification of a Novel Score for Adherence to the Mediterranean Diet That Is Inversely Associated with Visceral Adiposity and Cardiovascular Risk: The Chrono Med Diet Score (CMDS)
por: De Matteis, Carlo, et al.
Publicado: (2023)

Endocrine system dysfunction and chronic heart failure: a clinical perspective
por: Lisco, Giuseppe, et al.
Publicado: (2021)

Signal Transduction of Mineralocorticoid and Angiotensin II Receptors in the Central Control of Sodium Appetite: A Narrative Review
por: Iovino, Michele, et al.
Publicado: (2021)

Public Health Response to the SARS-CoV-2 Pandemic: Concern about Ultra-Processed Food Consumption
por: De Nucci, Sara, et al.
Publicado: (2022)

Trends in Coffee and Tea Consumption during the COVID-19 Pandemic
por: Castellana, Fabio, et al.
Publicado: (2021)

The TNAPP web-based algorithm improves thyroid nodule management in clinical practice: A retrospective validation study
por: Triggiani, Vincenzo, et al.
Publicado: (2023)

Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome
por: Piazzolla, Giuseppina, et al.
Publicado: (2019)

Erratum to “Hypogonadotropic Hypogonadism Associated with Hereditary Hemorrhagic Telangiectasia”
por: Scarano, Valentina, et al.
Publicado: (2013)

Hypogonadotropic Hypogonadism Associated with Hereditary Hemorrhagic Telengiectasia
por: Valentina, Scarano, et al.
Publicado: (2013)

The role of male hypogonadism, aging, and chronic diseases in characterizing adult and elderly men with erectile dysfunction: a cross-sectional study
por: Lisco, Giuseppe, et al.
Publicado: (2023)

Improvement of Left Ventricular Global Longitudinal Strain after 6-Month Therapy with GLP-1RAs Semaglutide and Dulaglutide in Type 2 Diabetes Mellitus: A Pilot Study
por: Basile, Paolo, et al.
Publicado: (2023)

Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D
por: Piazzolla, Giuseppina, et al.
Publicado: (2017)

Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
por: Menzen, Markus, et al.
Publicado: (2023)

Weekly Semaglutide vs. Liraglutide Efficacy Profile: A Network Meta-Analysis
por: Alsugair, Hassan A., et al.
Publicado: (2021)

The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS?
por: Jung, Han Na, et al.
Publicado: (2022)

COVID-19 and the Endocrine System: A Comprehensive Review on the Theme
por: Lisco, Giuseppe, et al.
Publicado: (2021)

Adverse reactions to food in patients with mastocytosis
por: Pucino, Valentina, et al.
Publicado: (2011)

Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature
por: Giudice, Valentina, et al.
Publicado: (2021)

Oral Semaglutide
por: Bui, Vinh, et al.
Publicado: (2018)

Safety of Semaglutide
por: Smits, Mark M., et al.
Publicado: (2021)

Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
por: Johansen, Pierre, et al.
Publicado: (2019)

Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes
por: Lisco, Giuseppe, et al.
Publicado: (2023)

Corticosteroids for Acute and Recurrent Idiopathic Pericarditis: Unexpected Evidences
por: Perrone, Antonio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a7ntftrd65184omj0mgnn48jf2